GS-6207

Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
Motley Fool
Sun, 03/24/19 - 12:08 pm
Gilead Sciences
GS-6207
HIV
Gilead shares early clinical data on HIV capsid inhibitor
Fierce Biotech
Fri, 03/8/19 - 11:35 am
Gilead Sciences
HIV
GS-6207
clinical trials